Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children.
Case Rep Crit Care
; 2023: 8530060, 2023.
Article
in English
| MEDLINE | ID: covidwho-2249209
ABSTRACT
Coronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist used to suppress the exaggerated inflammatory response in such conditions, and it is potentially lifesaving in a cytokine storm. We present the case of a patient with critical COVID-19 associated with multisystem inflammatory syndrome in children (MIS-C) successfully treated with anakinra intravenous (IV) infusion.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Journal:
Case Rep Crit Care
Year:
2023
Document Type:
Article
Affiliation country:
2023
Similar
MEDLINE
...
LILACS
LIS